Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $2.14 Million - $2.41 Million
-15,523 Reduced 44.27%
19,542 $3.03 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $4.68 Million - $5.42 Million
35,065 New
35,065 $5.23 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $214,745 - $247,311
-1,485 Reduced 7.85%
17,422 $2.78 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $2.62 Million - $3.14 Million
18,907 New
18,907 $3.06 Million
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $1.12 Million - $1.43 Million
-8,149 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $1.08 Million - $1.33 Million
8,149 New
8,149 $1.32 Million
Q2 2020

Aug 05, 2020

SELL
$73.37 - $98.18 $1.91 Million - $2.55 Million
-25,968 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$64.5 - $97.79 $1.67 Million - $2.54 Million
25,968 New
25,968 $1.98 Million
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $14.2 Million - $17.8 Million
-197,137 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$62.98 - $75.72 $10.7 Million - $12.9 Million
170,116 Added 629.57%
197,137 $14.9 Million
Q2 2019

Jul 08, 2019

BUY
$65.7 - $83.98 $1.57 Million - $2 Million
23,831 Added 747.05%
27,021 $1.97 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $87,785 - $103,319
-1,138 Reduced 26.29%
3,190 $257,000
Q4 2018

Feb 05, 2019

SELL
$77.85 - $96.01 $62,824 - $77,480
-807 Reduced 15.72%
4,328 $399,000
Q3 2018

Nov 02, 2018

SELL
$88.91 - $98.84 $51,923 - $57,722
-584 Reduced 10.21%
5,135 $0
Q2 2018

Aug 20, 2018

SELL
$89.78 - $106.23 $4.94 Million - $5.85 Million
-55,066 Reduced 90.59%
5,719 $0
Q1 2018

May 21, 2018

BUY
$92.01 - $123.21 $3.44 Million - $4.6 Million
37,370 Added 159.6%
60,785 $0
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $18.1 Million - $19.8 Million
-201,574 Reduced 89.59%
23,415 $2.26 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $5.48 Million - $7 Million
78,484 Added 53.57%
224,989 $20 Million
Q2 2017

Aug 17, 2017

BUY
N/A
146,505
146,505 $10.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.